Cardioloxía
Servicio
Complexo Hospitalario Universitario de Ourense
Orense, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Ourense (18)
2024
-
Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)
Journal of Clinical Medicine, Vol. 13, Núm. 9
-
Prevalence and prognosis of anxiety, insomnia, and type D personality in patients with myocardial infarction: A Spanish cohort
Cardiology journal, Vol. 31, Núm. 2, pp. 261-270
2023
-
Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19
Journal of Clinical Medicine, Vol. 12, Núm. 11
-
Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593
-
Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase
Primary Care Diabetes, Vol. 17, Núm. 4, pp. 366-372
-
Heart failure in older patients with atrial fibrillation: incidence and risk factors
Revista Espanola de Cardiologia
-
Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?
International Journal of Cardiology, Vol. 386, pp. 59-64
-
Outcomes and factors associated with mortality in patients with atrial fibrillation and heart failure: FARAONIC study
Clinical Cardiology, Vol. 46, Núm. 11, pp. 1390-1397
-
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)
Journal of Clinical Medicine, Vol. 12, Núm. 2
-
Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry
Frontiers in Endocrinology, Vol. 14
-
Takotsubo Syndrome, Stressful Triggers, and Risk of Recurrence
American Journal of Cardiology, Vol. 205, pp. 58-62
2022
-
Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy
Mayo Clinic Proceedings, Vol. 97, Núm. 2, pp. 261-273
-
Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes
Postgraduate Medicine, Vol. 134, Núm. 4, pp. 420-428
2021
2019
-
In-hospital postoperative infection after heart transplantation: Risk factors and development of a novel predictive score
Transplant Infectious Disease, Vol. 21, Núm. 4
2018
-
Rationale, design and preliminary results of the GALIPEMIAS study (prevalence and lipid control of familial dyslipidemia in Galicia, northwest Spain)
International Journal of Clinical Practice, Vol. 72, Núm. 9
2010
-
Factores pronósticos de mortalidad de la insuficiencia cardíaca en una cohorte del noroeste de España. Estudio EPICOUR
Revista Clinica Espanola, Vol. 210, Núm. 9, pp. 438-447
2001
-
Análisis del uso adecuado de los bloqueadores beta en el postinfarto
Revista Espanola de Cardiologia, Vol. 54, Núm. 11, pp. 1277-1282